Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 42Leukemia 34Lymphoma, Large B-Cell, Diffuse 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Leukemia, Myeloid, Acute 24Burkitt Lymphoma 19Leukemia, Myelomonocytic, Acute 16Lung Neoplasms 15Leukemia, Monocytic, Acute 15Neuroblastoma 14Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Lymphoma, Non-Hodgkin 13Lymphoma, Follicular 13Hodgkin Disease 12Congenital Abnormalities 12Carcinoma, Non-Small-Cell Lung 12Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, Mantle-Cell 10Central Nervous System Neoplasms 10Sarcoma 9Myelodysplastic Syndromes 9Anemia, Refractory, with Excess of Blasts 8Small Cell Lung Carcinoma 7Myeloproliferative Disorders 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Lymphocytic, Chronic, B-Cell 7Testicular Neoplasms 6Multiple Myeloma 6Lymphoma, B-Cell, Marginal Zone 6

Interventions

Temozolomide 6O(6)-benzylguanine 3Magnetic Resonance Spectroscopy 3Filgrastim 3Vorinostat 2Specimen Handling 2Radiotherapy 2Oxaliplatin 2Irinotecan 2Erlotinib Hydrochloride 2Carboplatin 2veliparib 1sargramostim 1romidepsin 1phenylacetic acid 1pembrolizumab 1palbociclib 1olaparib 1ixabepilone 1ispinesib 1erdafitinib 1cediranib 1becatecarin 1alvocidib 1X-Rays 1Verteporfin 1Thiotepa 1Tamoxifen 1Sunitinib 1RMP 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Familial ependymoma × Etoposide × Clear all
NCT00278252 2013-08-07

Etoposide in Treating Young Patients With Relapsed Ependymoma

National Cancer Institute (NCI)

Phase 2 Unknown
14 enrolled
CNS

Familial ependymoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡